Suspended procedures persuant to art. 35a SGB V

Discontinued procedures persuant to art. 35a SGB V

Start Resolution Procedure (no.) Brand name Pharm. company Therapeutic area Indication
Belimumab (3) (eingestellt) Benlysta® GlaxoSmithKline GmbH & Co. KG Musculoskeletal system diseases Lupus nephritis
Ceftolozan / Tazobactam (4) (eingestellt) Zerbaxa® MSD SHARP & DOHME GMBH Infectious diseases Ospital-acquired pneumonia, ventilator-associated pneumonia
Ceftolozan / Tazobactam (3) (eingestellt) Zerbaxa® MSD SHARP & DOHME GMBH Infectious diseases Complicated intra-abdominal infections
Ceftolozan / Tazobactam (2) (eingestellt) Zerbaxa® MSD SHARP & DOHME GMBH Infectious diseases Complicated urinary tract infections
Ceftolozan / Tazobactam Zerbaxa® MSD SHARP & DOHME GMBH Infectious diseases Acute pyelonephritis
Prasteron (eingestellt) Intrarosa® Endoceutics, Inc. Genitourinary system diseases Vulvovaginal atrophy
Ivacaftor (eingestellt) Kalydeco® Vertex Pharmaceuticals (Germany) GmbH Metabolic diseases ORPHAN Cystic fibrosis (CF), ≥ 12 years, combination with tezacaftor
Daratumumab (eingestellt) Darzalex® Janssen Cilag GmbH Oncological diseases ORPHAN Multiple myeloma (MM)
Ibrutinib (eingestellt) Imbruvica® Janssen-Cilag GmbH Oncological diseases ORPHAN Waldenström's disease
Bedaquilin (eingestellt) Sirturo® Janssen-Cilag GmbH Infectious diseases ORPHAN Multidrug-resistant pulmonary tuberculosis
Saxagliptin (eingestellt) Onglyza® Bristol-Myers Squibb GmbH & Co. KGaA / AstraZeneca GmbH Metabolic diseases Diabetes mellitus type 2, monotherapy
Rivaroxaban (eingestellt) Xarelto® Bayer Vital GmbH Cardiovascular diseases Prophylaxis / therapy of artherotrombotic / venothrombotic events
Denosumab (eingestellt) Prolia® Amgen GmbH Musculoskeletal system diseases Osteoporosis (postmenopausal), bone loss (prostate cancer)
Dabigatranetexilat (eingestellt) Pradaxa® Boehringer Ingelheim Pharma GmbH & Co. KG Cardiovascular diseases Prevention of venous thromboembolic events after hip or knee replacement and prevention of stroke and systemic embolism
Parathyroidhormon (eingestellt) PREOTACT® Takeda GmbH Musculoskeletal system diseases Osteoporosis (postmenopausal)
Retigabin (2) (eingestellt) Trobalt® GlaxoSmithKline GmbH & Co. KG Nervous system diseases Epilepsy, focal seizures
Olmesartanmedoxomil / Amlodipin / Hydrochlorothiazid (eingestellt) Sevikar HCT® Daiichi Sankyo Cardiovascular diseases Hypertension

Exempted procedures persuant to art. 35a SGB V

Start Resolution Procedure (no.) Brand name Pharm. company Therapeutic area Indication
Macimorelinacetate (freigestellt) Gryvelin® Consilient Health Ltd. Metabolic diseases Hypohysis function tests
Indigocarmin (freigestellt) Indigokarmin Serb® SERB SA Genitourinary system diseases Other diagnostics
Lutetium-(177Lu)-Oxodotreotid (freigestellt) Lutathera® Advanced Accelerator Applications Germany GmbH Oncological diseases ORPHAN Radiotherapy
Landiololhydrochlorid (freigestellt) Rapibloc® Amomed Pharma GmbH Cardiovascular diseases Tachycardia, atrial fibrillation or atrial flutter
Dinutuximab beta (freigestellt) Dinutuximab beta EUSA® EUSA Pharma (Germany) GmbH Oncological diseases ORPHAN Other antineoplastic agents
Delamanid (freigestellt) Deltyba® Otsuka Novel Products GmbH Infectious diseases ORPHAN Infections
Defibrotid (freigestellt) Defitelio® Gentium SpA Hematopoietic diseases ORPHAN Severe hepatic veno-occlusive disease in haematopoietic stem cell transplantation
Chloroprocain (freigestellt) Ampres® Meduna Arzneimittel GmbH Other diseases Spinal anaesthesia
Piperaquintetraphosphat / Dihydroartemisinin (freigestellt) Eurartesim® sigma-tau Arzneimittel GmbH Infectious diseases Antimalarial
Ceftarolinfosamil (freigestellt) Zinforo® AstraZeneca GmbH Infectious diseases Beta-lactam antibiotic
Dexmedetomidin (freigestellt) Dexdor® Orion Corporation Other diseases Hypnotics and sedatives, parenteral